A DPYD Variant (Y186C) Specific to Individuals of African Descent in a Patient With Life-Threatening 5-FU Toxic Effects: Potential for an Individualized Medicine Approach
Open Access
- 1 January 2014
- journal article
- case report
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 89 (1), 131-136
- https://doi.org/10.1016/j.mayocp.2013.09.008
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A DPYD Variant (Y186C) in Individuals of African Ancestry Is Associated With Reduced DPD Enzyme ActivityClinical Pharmacology & Therapeutics, 2013
- Simultaneous detection of variable number tandem repeats, single nucleotide polymorphisms, and allelic imbalance in the thymidylate synthase gene enhancer region using denaturing high-performance liquid chromatographyAnalytical Biochemistry, 2004
- Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-based ChemotherapyClinical Cancer Research, 2004
- A High-Throughput Denaturing High-Performance Liquid Chromatography Method for the Identification of Variant Alleles Associated with Dihydropyrimidine Dehydrogenase DeficiencyAnalytical Biochemistry, 2002
- Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structureBiochemical Journal, 2002
- Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapyThe Pharmacogenomics Journal, 2001
- Evaluation of dihydropyrimidine dehydrogenase activity in South-west Asian, Kenyan and Ghanaian populationsBritish Journal of Clinical Pharmacology, 2000
- Metabolism of pyrimidine analogues and their nucleosidesPharmacology & Therapeutics, 1990
- Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion.1990
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989